Literature DB >> 3748012

Immunochemical structure of the hepatitis B surface antigen vaccine--II. Analysis of antibody responses in human sera against the envelope proteins.

M A Petit, P Maillard, F Capel, J Pillot.   

Abstract

Antibody responses to the three envelope (env) proteins of hepatitis B viral particles (HB-VP): the S-encoded P25 polypeptide; the pre-S(2)- and S-encoded GP33/GP36 polypeptide; and the large entire env gene (pre-S + S) product, P39/GP42, were investigated using a Western immunoblotting assay (WIBA). HB-VP proteins separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose by electroblotting were used as antigenic probes to determine the polypeptide specificity of these antibodies present in immune individuals. Antisera from human subjects either after a natural HBV infection or after active immunization with the hepatitis B vaccine licensed in France were selected on the basis of a positive serological RIA test for antibodies against hepatitis B surface antigen (HBsAg). In all studied cases, the lack of reactivity of the anti-HBs/P25 antibodies in blots from reduced SDS gels confirms that the S-related-determinants have a conformation sensitive to denaturing agents. In contrast, the anti-pre-S(2)/GP33-GP36 antibodies and the anti-pre-S(1)/P39-GP42 antibodies can be easily detected in WIBA, providing these antibodies recognize the disulfide-bond independent pre-S determinants on the denatured env proteins. However, antisera raised in guinea-pigs against individual HBsAg polypeptides contain antibodies reacting with denatured S-proteins, suggesting that the sequential S-determinants are lost during HBV morphogenesis. Antibody responses in HBV convalescing patients or vaccinated healthy donors are shown to be characterized by: an early transient polypeptide specific-antibody response to pre-S(2)-sequences (detected in WIBA); a persistent antibody response to conformation-dependent S-determinants (detected in RIA). This implies that effective long-term protection against HBV infection requires antibodies directed to native env proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3748012     DOI: 10.1016/0161-5890(86)90114-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  HBsAg in urine: a new approach for the detection of urinary antigens.

Authors:  S Badur; L Grangeot-Keros; J Pillot
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

Review 2.  Overview of hepatitis B virus mutations and their implications in the management of infection.

Authors:  Patrizia Caligiuri; Rita Cerruti; Giancarlo Icardi; Bianca Bruzzone
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  The humoral immune response in acute and chronic hepatitis B virus infection.

Authors:  D R Milich; M Sallberg; T Maruyama
Journal:  Springer Semin Immunopathol       Date:  1995

4.  Cloning, expression, isolation and characterization of the pre-S domains of hepatitis B surface antigen, devoid of the S protein.

Authors:  S Delos; M T Villar; P Hu; D L Peterson
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

5.  In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus.

Authors:  R Bchini; F Capel; C Dauguet; S Dubanchet; M A Petit
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Multiple epitopes of hepatitis B virus surface antigen targeted by human plasma-derived immunoglobulins coincide with clinically observed escape mutations.

Authors:  Sreya Tarafdar; Maria Luisa Virata; Hailing Yan; Lilin Zhong; Lu Deng; Yanqun Xu; Yong He; Evi Struble; Pei Zhang
Journal:  J Med Virol       Date:  2021-08-26       Impact factor: 20.693

7.  Applicability of oral fluid samples for tracking hepatitis B virus mutations, genotyping, and phylogenetic analysis.

Authors:  Moyra Machado Portilho; Cristianne Sousa Bezerra; Ana Carolina da Fonseca Mendonça; Vanessa Alves Marques; Leticia Cancella Nabuco; Cristiane Alves Villela-Nogueira; Cláudia Alexandra Pontes Ivantes; Lia Laura Lewis-Ximenez; Bárbara Vieira do Lago; Livia Melo Villar
Journal:  Arch Virol       Date:  2021-06-19       Impact factor: 2.574

8.  Nucleotide Substitutions in Hepatitis B Viruses Derived from Chronic HBV Patients.

Authors:  Narjes Shokatpour; Maryam Vaezjalali; Graham R Foster; Shahnaz Sali
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-07-01       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.